India to Iraq: Empagliflozin Export Trade Route
India has recorded 26 verified shipments of Empagliflozin exported to Iraq, representing a combined trade value of $330.6K USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $12.7K USD. The leading Indian exporter is SAM LIFESTYLE, which accounts for 21% of total export value with 5 shipments worth $68.2K USD. On the buying side, ALSHIFA PHARMA SCIENTIFIC DRUG is the largest importer in Iraq with $68.2K USD in purchases. The top 3 suppliers — SAM LIFESTYLE, SCOTT EDIL PHARMACIA LIMITED, ARZNEIMITTEL-ALFA PRIVATE LIMITED — together control 49% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Empagliflozin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $330.6K USD. The route is dominated by SAM LIFESTYLE, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $12.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (38.5%) and air (46.2%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 5.0%, placing it at rank #12 among India's top empagliflozin export destinations globally.
On the import side, key buyers of Indian empagliflozin in Iraq include ALSHIFA PHARMA SCIENTIFIC DRUG, TO THE ORDER OF, DIAGNOSTIC WAY LLC and 10 others. ALSHIFA PHARMA SCIENTIFIC DRUG is the single largest importer with 5 shipments valued at $68.2K USD.
